Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture
Author:
Affiliation:
1. Universidad de Buenos Aires, Área Investigación, Instituto de Oncología Ángel H. RoffoBuenos AiresArgentina
Funder
Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.26298
Reference31 articles.
1. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2. Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
3. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
4. Molecular mechanisms of trastuzumab resistance in HER2 overexpressing Breast cancer;Fiszman GL;J Breast Cancer,2011
5. The tumor microenvironment is a dominant force in multidrug resistance
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomic Characterization of a 3D HER2+ Breast Cancer Model Reveals the Role of Mitochondrial Complex I in Acquired Resistance to Trastuzumab;International Journal of Molecular Sciences;2024-07-05
2. Assessing the distribution of cancer stem cells in tumorspheres;Scientific Reports;2024-05-14
3. Biological mechanisms of resistance to trastuzumab and ways to overcome them: Mod-ern problems of clinical oncology;Regulatory Mechanisms in Biosystems;2024-05-11
4. Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance;Cellular and Molecular Bioengineering;2024-02-21
5. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells;Journal of Liposome Research;2024-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3